*From the Author*:

I thank Prof. Lipworth and Dr. Kuo for their comments on our manuscript ([@bib1]). Our attempt is the first of its kind to link patient-based computational models of the small airways with patient outcome measures. In line with the comments made by Prof. Lipworth with respect to resistance at 5 Hz (R5) − resistance at 20 Hz (R20) and asthma risk in cross-sectional studies, I and others recently reported the results of the ATLANTIS (Assessment of Small Airways Involvement in Asthma) study, a large multinational study evaluating the association of small airway disease with adult asthma outcomes ([@bib2]).

ATLANTIS clearly identified that the oscillometry measure R5 − R20 was one of the strongest predictors of both asthma control and prior asthma exacerbations among all the potential small airway indices.

The combination of our findings ([@bib1]) with the ATLANTIS study results ([@bib2]) should now enable investigators to test interventions that target the small airways, with R5 − R20 as an outcome measure.
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